<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>4</Volume>
				<Issue>11</Issue>
				<PubDate PubStatus="epublish">
					<Year>2015</Year>
					<Month>11</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Comparison of Blood Transfusion Plus Chelation Therapy and Bone Marrow Transplantation in Patients with β-Thalassemia: Application of SF-36, EQ-5D, and Visual Analogue Scale Measures</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>733</FirstPage>
			<LastPage>740</LastPage>
			<ELocationID EIdType="pii">3041</ELocationID>
			
<ELocationID EIdType="doi">10.15171/ijhpm.2015.113</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Mehdi</FirstName>
					<LastName>Javanbakht</LastName>
<Affiliation>Health  Economics  Research  Unit,  Institute  of  Applied  Health  Sciences, 
University  of  Aberdeen,  Aberdeen,  UK</Affiliation>

</Author>
<Author>
					<FirstName>Ali</FirstName>
					<LastName>Keshtkaran</LastName>
<Affiliation>Health  Economics  Department, 
School of Management and Information Sciences, Shiraz University of Medical 
Sciences, Shiraz, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Hossien</FirstName>
					<LastName>Shabaninejad</LastName>

						<AffiliationInfo>
						<Affiliation>Department of Health Services Management, School 
of  Health  Management  and  Information  Sciences,  Iran  University  of  Medical 
Sciences, Tehran, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Health Management and Economics Research Center, 
Iran  University  of  Medical  Sciences,  Tehran,  Iran</Affiliation>
						</AffiliationInfo>

</Author>
<Author>
					<FirstName>Hassan</FirstName>
					<LastName>Karami</LastName>
<Affiliation>Health  Economics  Department, 
School of Management and Information Sciences, Shiraz University of Medical 
Sciences, Shiraz, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Maryam</FirstName>
					<LastName>Zakerinia</LastName>
<Affiliation>Department  of  Internal 
Medicine,  BMT  Unit,  Hematology  Research  Center,  and  Organ  Transplant 
Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, 
Shiraz,  Iran</Affiliation>

</Author>
<Author>
					<FirstName>Sajad</FirstName>
					<LastName>Delavari</LastName>
<Affiliation>Department  of  Health  Management  and  Economics,  School  of 
Public Health, Tehran University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2015</Year>
					<Month>01</Month>
					<Day>02</Day>
				</PubDate>
			</History>
		<Abstract>Background &lt;br /&gt;β-Thalassemia is a prevalent genetic disease in Mediterranean countries. The most common treatments for this disease are blood transfusion plus iron chelation (BTIC) therapy and bone marrow transplantation (BMT). Patients using these procedures experience different health-related quality of life (HRQoL). The purpose of the present study was to measure HRQoL in these patients using 2 different multiattribute quality of life (QoL) scales. &lt;br /&gt;  &lt;br /&gt;Methods &lt;br /&gt;In this cross-sectional study, data were gathered using 3 instruments: a socio-demographic questionnaire, EQ-5D, and SF-36. A total of 196 patients with β-thalassemia were randomly selected from 2 hospitals in Shiraz (Southern Iran). Data were analyzed using logistic regression and multiple regression models to identify factors that affect the patients’ HRQoL. &lt;br /&gt;  &lt;br /&gt;Results &lt;br /&gt;The average EQ-5D index and EQ visual analog scale (VAS) scores were 0.86 (95% CI: 0.83–0.89) and 71.85 (95% CI: 69.13–74.58), respectively. Patients with BMT reported significantly higher EQ VAS scores (83.27 vs 68.55, respectively). The results showed that patients who lived in rural area and patients with BMT reported higher EQ VAS scores (rural; β=10.25, P=.006 and BMT; β=11.88, P=.000). As well, SF-36 between 2 groups of patients were statistically significant in physical component scale (PCS). &lt;br /&gt;  &lt;br /&gt;Conclusion &lt;br /&gt;Patients in the BMT group experienced higher HRQoL in both physical and mental aspects compared to those in the BTIC group. More studies are needed to assess the relative cost-effectiveness of these methods in developing countries</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">β-Thalassemia</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Health Related Quality of Life (HRQoL)</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Blood Transfusion</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Bone Marrow</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Transplantation (BMT)</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_3041_7ed27d122e85f72312fc53d815b891a3.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
